Influenza, Human

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

NCT03314662 | PHASE 3 | INTERVENTIONAL

This phase 3 study is a randomized, double-blinded, comparator controlled, parallel-group, multicenter study of aQIV versus the US-licensed 2017-2018 adjuvanted trivalent influenza vaccine (aTIV-1, Fluad), and versus an adjuvanted trivalent influenza vaccine (aTIV-2), containing the alternate B strain.

20 Sites

1778 Participants

Recruiting

65 Years to 45 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Find closest sites:

SUBMIT

Coastal Clinical Research, Inc.

Mobile,Alabama,United States,36608

Anaheim Clinical Trials

Anaheim,California,United States,92801

Paradigm clinical Research Centers, Inc

Redding,California,United States,96001

Clinical Research of South Florida, an AMR Company

Coral Gables,Florida,United States,33134

Meridan Clinical Research, LLC

Savannah,Georgia,United States,31406

Advanced Clinical Research

Meridian,Idaho,United States,83642

Johnson County ClinTrials

Lenexa,Kansas,United States,66219

Heartland Research Associates, LLC An AMR Company

Newton,Kansas,United States,67114

Heartland Research Associates, LLC An AMR Company

Wichita,Kansas,United States,67207

Center for Pharmaceutical Research, LLC

Kansas City,Missouri,United States,64114

Sundance Clinical Research, LLC

Saint Louis,Missouri,United States,63141

Meridian Clinical Research, LLC

Omaha,Nebraska,United States,68134

United Medical Associates

Binghamton,New York,United States,13901

Rapid Medical Research, Inc.

Cleveland,Ohio,United States,44122

Medical Research South

Charleston,South Carolina,United States,29407

New Orleans Center for Clinical Research

Knoxville,Tennessee,United States,37920

Benchmark Research

Fort Worth,Texas,United States,76135

Benchmark Research

San Angelo,Texas,United States,76904

Martin Diagnostic Clinic

Tomball,Texas,United States,77375

Advanced Clinical Research

West Jordan,Utah,United States,84088

Study Eligibility Criteria

Inclusion Criteria

* Males and females ≥ 65 years old who are healthy or have co-morbidities
* Individuals who or whose legal representative(s) have voluntarily given written consent after the nature of the study has been explained according to local regulatory requirements, prior to study entry
* Ability to attend all scheduled visits and to comply with study procedures including diary card completion and follow-up

Exclusion Criteria

* History of behavioral or cognitive impairment or psychiatric condition
* Hypersensitivity, including allergy, to any component of vaccines, medicinal products or medical equipment whose use is foreseen in this study
* Abnormal function of the immune system
* Receipt of any influenza vaccine within 6 months prior to enrollment in this study, or plan to receive influenza vaccine prior to the Day 22 blood collection
* Any other clinical condition that, in the opinion of the Investigator, might interfere with the results of the study or pose additional risk to the subject due to participation in the study
Additional eligibility criteria may be discussed by contacting the site.

Additional Studies

Additional studies can be found at ClinicalTrials.gov